Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
2023 · International Journal of Obesity · 48 citations
https://doi.org/10.1038/s41366-023-01337-x
S
Sara Almeida Cruz
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
88
Citations
4
h-index
3
i10-index
Sara Almeida Cruz is an academic researcher from Immanuel Kant Baltic Federal University. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Diabetes Treatment and Management & Metabolism, Diabetes, and Cancer. The author has an h-index of 4, co-authored 6 publications.
ORCID: 0000-0003-2814-9627Papers by this author
worksShorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis
2022 · European Journal of Pediatrics · 15 citations
https://doi.org/10.1007/s00431-022-04603-8
Reflectance confocal microscopy for margin mapping of melanoma of the lentigo maligna type: A systematic review and meta‐analysis
2024 · Journal of the European Academy of Dermatology and Venereology · 12 citations
https://doi.org/10.1111/jdv.20383
Safety and efficacy of topical nitric <scp>oxide‐releasing</scp> berdazimer gel for molluscum contagiosum clearance: A systematic review and <scp>meta‐analysis</scp> of randomized controlled trials
2023 · Pediatric Dermatology · 5 citations
https://doi.org/10.1111/pde.15419
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat